Genstar GNT(formerly UroGen)-- an interesting speculation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genstar GNT(formerly UroGen)-- an interesting speculation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Lee who started this subject	5/8/2002 7:41:01 AM
From: Paul Lee	of 100

GenStar Therapeutics Announces Research Agreement with Centocor BUSINESS WIRE - May 08, 2002 07:33 SAN DIEGO, May 8, 2002 (BW HealthWire) -- GenStar Therapeutics (AMEX: GNT) announced today that it has entered into a research agreement with Centocor Inc., employing GenStar's viral gene delivery technology. As part of the agreement, GenStar will develop gene delivery vectors that will be evaluated in preclinical studies to be performed by Centocor, a Johnson & Johnson company. Financial terms were not disclosed. "We are very pleased that a leading biotechnology company such as Centocor has teamed with GenStar for this research agreement," said Robert E. Sobol, M.D., GenStar's Chief Executive Officer.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next